Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 515 results found. Search for [ Sun Pharma news ]

Results 460 to 480 of 515
BT Online Bureau
New Delhi, May 22, 2015
Overall market breadth remained weak on the BSE as 1,195 stocks ended with gains while 1,519 closed with losses.

BT Online Bureau
New Delhi, April 23, 2015
Key stocks that made news today were YES Bank, Jet Airways, HDFC Bank and Biocon.

BT Online Bureau
April 20, 2015
Though there is not a single business news story which can be termed less important, there are some which stand out among those we cover during a day. Here are the top five of them which we found the most relevant today.

Mumbai, April 20, 2015
This was the fourth consecutive session of fall in Sensex, which has now lost around 1,160 points since crossing 29,000-levels last Monday. Concerns by foreign investors over retrospective taxation weighed on sentiments, traders said.

BT Online Bureau
New Delhi, April 16, 2015
Check out the six key stocks that made news today.

Mumbai, March 11, 2015
Metal, oil and gas, healthcare, capital goods and technology stocks witnessed selling pressure.
March 7, 2015
What made news this past fortnight - Dilip Shanghvi became India's richest, China's economic growth and more.

Shoaib Zaman
March 1, 2015
The benchmark index, Sensex registered a marginal gain of 0.48%. However, the difference between the day's high and low was 678.3 points.

Mumbai, February 13, 2015
Besides, expectations of faster reforms and a growth oriented Budget as well as recent data strengthening the case for more monetary easing boosted the sentiment, brokers said.

John C Gonsalves and V M Prabhune
Mumbai, December 25, 2014
In percentage terms also, the rally this year is the biggest since 2009 (81 per cent).

E Kumar Sharma
December 24, 2014
Sun Pharmaceutical's move to acquire Ranbaxy is arguably the high point of 2014 for the pharmaceutical sector.

Suveen Sinha and Ajay Modi
November 20, 2014
The families of Fortis-Religare, Jubilant, Emami and DCM Shriram present a heartwarming contrast to the all around upheaval in family-run businesses.

Mahesh Nayak
September 1, 2014
The equity market is likely to remain firm on the back of positive developments like the fall in oil prices, a stronger rupee and impressive first quarter GDP numbers.

Mumbai, July 3, 2014
A total of 447 stocks touched their 52-week highs on the BSE, including Lupin, Ranbaxy Lab, Strides Arcolab, Sun Pharma, Tata Motors, Tech Mahindra and TVS Motor.

E. Kumar Sharma
July 2, 2014
Given the optimistic mood in the country about the reform process, Satish Reddy, President of the Indian Pharmaceutical Alliance (IPA) and Chairman at Dr Reddy's Labs, said that \"the industry will be looking for signals of revival of the growth story\".

Mumbai, July 1, 2014
Buying by foreign funds amid positive global cues also boosted the domestic sentiment. The decision to increase diesel, petrol and non-subsidised LPG prices after hiking railway freight and fare was interpreted by investors as the government's resolve to take tough decisions, said brokers.

Santhosh Babu
June 26, 2014
Why Sun Pharma should know the hidden networks in Ranbaxy

E. Kumar Sharma
May 31, 2014
In the seven years since, Mylan Inc has invested around $3 billion on acquisitions in India. It now regards India not just as a global sourcing hub, but also as a market.

Manoj Kumar
May 1, 2014
Commerce Secretary Rajeev Kher praised a decision by the US Trade Representative not to label India with its worst offender tag in an annual scorecard on protecting U.S. patents, copyrights and other intellectual property.

E. Kumar Sharma
April 23, 2014
Ranbaxy is Sun Pharma's 17th acquisition, and by far its biggest to date. Soon after the Ranbaxy deal, Sun's founder, Dilip Shanghvi said his decision was driven by the \"underlying business in India and emerging markets, and its robust pipeline and profitability\".

PAGES 24 OF 26  2122232425